These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16638842)

  • 1. Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena.
    Melero I; Arina A; Murillo O; Dubrot J; Alfaro C; Pérez-Gracia JL; Bendandi M; Hervás-Stubbs S
    Clin Cancer Res; 2006 Apr; 12(8):2385-9. PubMed ID: 16638842
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
    Ishida A; Tanaka H; Hiura T; Miura S; Watanabe S; Matsuyama K; Kuriyama H; Tanaka J; Kagamu H; Gejyo F; Yoshizawa H
    Scand J Immunol; 2007 Nov; 66(5):546-54. PubMed ID: 17953530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].
    Yao LC; Yang RJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2552-6. PubMed ID: 18067832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity.
    Park MY; Kim CH; Sohn HJ; Oh ST; Kim SG; Kim TG
    Vaccine; 2007 Oct; 25(42):7322-30. PubMed ID: 17889413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
    J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.
    Tamai H; Watanabe S; Zheng R; Deguchi K; Cohen PA; Koski GK; Shu S
    Clin Immunol; 2008 Apr; 127(1):66-77. PubMed ID: 18262845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI; Kim EK; Park SY; Lee SK; Hong YK; Kim TG
    Cancer Lett; 2007 Dec; 258(2):189-98. PubMed ID: 17931768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with beta(2)-microglobulin-deficient dendritic cells protects against growth of beta(2)-microglobulin-deficient tumours.
    Dammeyer P; Mwakigonja AR; Rethi B; Chiodi F; Wolpert EZ
    Scand J Immunol; 2009 Jul; 70(1):44-52. PubMed ID: 19522767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.
    Ullrich E; Bonmort M; Mignot G; Chaput N; Taieb J; Ménard C; Viaud S; Tursz T; Kroemer G; Zitvogel L
    Cancer Res; 2007 Feb; 67(3):851-3. PubMed ID: 17283111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
    Jeong HS; Lee H; Ko Y; Son YI
    Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells.
    Savai R; Schermuly RT; Pullamsetti SS; Schneider M; Greschus S; Ghofrani HA; Traupe H; Grimminger F; Banat GA
    Cancer Res; 2007 Jun; 67(11):5443-53. PubMed ID: 17545626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 'good death' for tumor immunology.
    Storkus WJ; Falo LD
    Nat Med; 2007 Jan; 13(1):28-30. PubMed ID: 17206130
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.
    Linke A; Brossart P; Schmidt-Wolf IG; Gonzalez-Carmona MA; Ziske C; Messmer D; Schmitz V; Sauerbruch T
    Pancreas; 2009 Jul; 38(5):602-4. PubMed ID: 19550282
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy.
    Skitzki JJ; Muhitch JB; Evans SS
    Immunol Invest; 2007; 36(5-6):807-27. PubMed ID: 18161530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.